Effect	effect	O	O	O	O
of	of	O	O	O	O
nifedipine	nifedipine	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
renal	renal	O	O	O	O
function	function	O	O	O	O
in	in	O	O	O	O
liver	liver	O	O	O	O
transplant	transplant	O	O	O	O
recipients	recipients	O	O	O	O
receiving	receiving	O	O	O	O
tacrolimus	tacrolimus	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
nifedipine	nifedipine	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
renal	renal	O	O	O	O
function	function	O	O	O	O
in	in	O	O	O	O
liver	liver	O	O	O	O
transplant	transplant	O	O	O	O
recipients	recipients	O	O	O	O
who	who	O	O	O	O
were	were	O	O	O	O
receiving	receiving	O	O	O	O
tacrolimus	tacrolimus	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
evaluated	evaluated	O	O	O	O
between	between	O	O	O	O
January	january	O	O	O	O
1992	1992	O	O	O	O
and	and	O	O	O	O
January	january	O	O	O	O
1996	1996	O	O	O	O
.	.	O	O	O	O

Two	two	O	O	O	O
groups	groups	O	O	O	O
of	of	O	O	O	O
patients	patients	O	O	O	O
receiving	receiving	O	O	O	O
tacrolimus	tacrolimus	CHEMICALS	O	OTHERS	I
were	were	O	O	O	O
compared	compared	O	O	O	O
over	over	O	O	O	O
a	a	O	O	O	O
period	period	O	O	O	O
of	of	O	O	O	O
1	1	O	O	O	O
year	year	O	O	O	O
,	,	O	O	O	O
one	one	O	O	O	O
group	group	O	O	O	O
comprising	comprising	O	O	O	O
hypertensive	hypertensive	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
who	who	O	O	O	O
were	were	O	O	O	O
receiving	receiving	O	O	O	O
nifedipine	nifedipine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
other	other	O	O	O	O
comprising	comprising	O	O	O	O
nonhypertensive	nonhypertensive	O	O	O	O
patients	patients	O	O	O	O
not	not	O	O	O	O
receiving	receiving	O	O	O	O
nifedipine	nifedipine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
time	time	O	O	O	O
from	from	O	O	O	O
transplant	transplant	O	O	O	O
to	to	O	O	O	O
baseline	baseline	O	O	O	O
was	was	O	O	O	O
similar	similar	O	O	O	O
in	in	O	O	O	O
all	all	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

Nifedipine	nifedipine	CHEMICALS	O	OTHERS	I
significantly	significantly	O	O	O	O
improved	improved	O	O	O	O
kidney	kidney	O	O	O	O
function	function	O	O	O	O
as	as	O	O	O	O
indicated	indicated	O	O	O	O
by	by	O	O	O	O
a	a	O	O	O	O
significant	significant	O	O	O	O
lowering	lowering	O	O	O	O
of	of	O	O	O	O
serum	serum	O	O	O	O
creatinine	creatinine	CHEMICALS	O	OTHERS	I
levels	levels	O	O	O	O
at	at	O	O	O	O
6	6	O	O	O	O
and	and	O	O	O	O
12	12	O	O	O	O
months	months	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
observed	observed	O	O	O	O
positive	positive	O	O	O	O
impact	impact	O	O	O	O
of	of	O	O	O	O
nifedipine	nifedipine	CHEMICALS	O	OTHERS	I
on	on	O	O	O	O
reducing	reducing	O	O	O	O
the	the	O	O	O	O
nephrotoxicity	nephrotoxicity	O	DISEASE	OTHERS	I
associated	associated	O	O	O	O
with	with	O	O	O	O
tacrolimus	tacrolimus	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
liver	liver	O	O	O	O
transplant	transplant	O	O	O	O
recipients	recipients	O	O	O	O
should	should	O	O	O	O
be	be	O	O	O	O
an	an	O	O	O	O
important	important	O	O	O	O
factor	factor	O	O	O	O
in	in	O	O	O	O
selecting	selecting	O	O	O	O
an	an	O	O	O	O
agent	agent	O	O	O	O
to	to	O	O	O	O
treat	treat	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
in	in	O	O	O	O
this	this	O	O	O	O
population	population	O	O	O	O
.	.	O	O	O	O

